Skip to main content
Clinical Trials/CTRI/2021/08/035502
CTRI/2021/08/035502
Not yet recruiting
未知

Comparison of clinical and inflammatory markers for dry eye disease following phacoemulsification and manual small incision cataract surgery

JIPMER0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
JIPMER
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
JIPMER

Eligibility Criteria

Inclusion Criteria

  • Patients with senile cataract above the age of 40 years undergoing cataract surgery by MSICS or phacoemulsification

Exclusion Criteria

  • 1\.Patients developing intra\-operative or post\- operative complications.
  • 2\.Glaucoma patients undergoing cataract surgery on prior topical anti\-glaucoma medications.
  • 3\.Patients using any topical medications on a long\-term basis for other ocular conditions like glaucoma, uveitis, etc.
  • 4\.Patients with lid abnormalities (entropion, ectropion, trichiasis) or exposure changes due to thyroid eye disease or facial nerve palsy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
DH and Ferritin levels in Diabetes Mellitus.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: E086- Diabetes mellitus due to underlying condition with other specified complications
CTRI/2021/03/031970Self
Not yet recruiting
Not Applicable
Inflammatory markers and other biochemical parameters in COVID -19 and their association with mortality outcome in Diabetes verses Non Diabetes patients of coastal karnataka tertiary care hospital.
CTRI/2020/12/030070Dr Shaheen B shaikh
Completed
Not Applicable
Examination of inflammatory markers associated with Total Knee Replacement surgery, and the association with coagulopathies (bleeding/clotting disorders)
ACTRN12617000444381Orthopaedic Research Institute of Queensland (ORIQL)20
Active, not recruiting
Phase 1
Examining the effects of eye drops on changes in inflammation on the surface of the eyeGlaucoma is the condition that is being treated by these eye drops - however the study is aimed at measuring the amount of inflammation that develops on the surface of the eye when these drops are usedMedDRA version: 14.1 Level: HLGT Classification code 10018307 Term: Glaucoma and ocular hypertension System Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2013-000581-10-GBottingham University NHS Trust100
Active, not recruiting
Phase 1
Evaluation of inflammatory markers in patients undergoing a short-term aerobic exercise program while hospitalized due to acute exacerbation of COPDChronic obstructive pulmonary disease with acute lower respiratory infectionJ44.0
RBR-7yv765Faculdade de Medicina de Botucatu /UNESP